Cymevene 500 mg Powder for Infusion, (ganciclovir), 50 mg/mL ganciclovir (reconstructed), Rx only...

FDA Recall #D-105-2013 — Class II — September 5, 2012

Recall #D-105-2013 Date: September 5, 2012 Classification: Class II Status: Terminated

Product Description

Cymevene 500 mg Powder for Infusion, (ganciclovir), 50 mg/mL ganciclovir (reconstructed), Rx only, 10 mL vials, Roche Products Limited, Welwyn Garden City, AL7 1TW, United Kingdom

Reason for Recall

Lack of Assurance of Sterility; container closure issues with the bulk batch.

Recalling Firm

F. Hoffmann-LaRoche Ltd. — Basel, N/A

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

42010 vials

Distribution

No product distributed in the USA. Bulk product distributed to Switzerland, with further distribution in Europe, Scandinavia, Korea.

Code Information

bulk lot N0019, Expiration Date: 11 2014 Warennummer: 10131968 Chargennummer:NXXXX 2000609D Finished product Lot N0019B01-N0019B12

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated